𝗪𝗲 𝗮𝗿𝗲 𝗿𝗲𝗱𝗲𝗳𝗶𝗻𝗶𝗻𝗴 𝗰𝗲𝗿𝘃𝗶𝗰𝗮𝗹 𝘀𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴

10zyme is engineering biology to develop an innovative diagnostic technology that will empower women to effectively control their cervical health.

As an early-stage UK MedTech startup, we are pioneering a visionary approach to cervical screening. Our unique self-test will deliver instant results for high-risk HPV, the virus responsible for over 99% of all cervical cancers.

𝗦𝗲𝗹𝗳-𝘁𝗲𝘀𝘁 𝘃𝘀. 𝘀𝗲𝗹𝗳-𝗰𝗼𝗹𝗹𝗲𝗰𝘁𝗶𝗼𝗻

10zyme’s self-testing solution will provide immediate, reliable results wherever and whenever the test is taken. In comparison, self-collection/ sampling methods developed elsewhere only offer an alternative means of sample collection that still require transportation and laboratory testing, therefore leading to delays in obtaining results.

Self-testing will significantly increase screening uptake whilst reducing strain on vital healthcare resources, providing an accessible, convenient, and life-saving cancer prevention solution to all.

𝗕𝗲𝗻𝗲𝗳𝗶𝘁𝘀 𝗼𝗳 𝗼𝘂𝗿 𝗛𝗣𝗩 𝘀𝗲𝗹𝗳-𝘁𝗲𝘀𝘁 𝘄𝗶𝘁𝗵 𝗶𝗻𝘀𝘁𝗮𝗻𝘁 𝗿𝗲𝘀𝘂𝗹𝘁𝘀:

• Non-invasive and simple to use
• Provides sensitive and accurate results compared to lab-based tests
• Increases cervical screening uptake
• Reduces strain on vital healthcare resources
• Provides an accessible, convenient, and life-saving cancer prevention solution to all

10zyme

Org chart

Teams

Offices

10zyme

Org chart

Teams

Offices

Related companies